High-throughput microelectrode array (MEA) and impedance equipment

Published

19 February 2026

Procedure

neg-wo-call

Lots

1

Notice number

00120362-2026

Reference

7372996c-123b-48d1-96a9-b47058b745f0

Official source

Official source

CPV codes

• 38000000Equipo de laboratorio, óptico y de precisión (excepto gafas)

Description

Microelectrode array (MEA) systems are novel tools in electrophysiology that will help the basic and preclinical research on brain and cardiac diseases with a goal to efficiently translate preclinical research findings into efficient treatment, prevention and diagnosis. Electrophysiological techniques allow comprehensive understanding of the biological basis of functioning of these cell types in health and in pathological conditions. MEA technology is one of the core methods to study e.g. electrophysiological characteristics of neuronal and cardiac cells and their function both in normal and diseased conditions. High-throughput MEA instruments allow also drug discovery for neurological and cardiovascular diseases and investigation of novel therapeutic targets/treatments in human cell-based models in vitro. Instrument with integrated impedance technology allows also cell viability and neuro/cardio-toxicity analysis, which are highly relevant for early safety assessment of new drug leads. Minimum technical specifications required from the high-throughput microelectrode array (MEA) and impedance equipment to be purchased are: • Enables medium to high throughput analysis i.e. at least…

Awards

Frequently asked questions

Who is the buyer of this tender?

The contracting authority is Helsingin yliopisto (European Union).